Mupirocin

Ondine Successfully Raised C$4.91 Million to Support Acceleration of Its Commercial Rollout of Nasal Decolonization to Prevent Healthcare-associated Infections

Retrieved on: 
Wednesday, December 13, 2023
Medical Devices, Health, Hospitals, Surgery, Health Technology, Biotechnology, SSI, Nose, Patient, Fungus, FDA, Mupirocin, Vancouver General Hospital, Christianity in Singapore, Bacteria, Virus, Hospital, Society, HCA, Fungal infection, Bloodstream infections, Pharmaceutical industry

Following its successful fundraising of C$4.91 million (US$3.62), Canadian life sciences company Ondine Biomedical Inc. will continue accelerating commercialisation of its proven nasal photodisinfection technology.

Key Points: 
  • Following its successful fundraising of C$4.91 million (US$3.62), Canadian life sciences company Ondine Biomedical Inc. will continue accelerating commercialisation of its proven nasal photodisinfection technology.
  • This cutting-edge technology replaces topical antibiotics for the prevention of healthcare-associated infections (HAIs) and kills all types of pathogens – bacteria, viruses and fungi – without causing antimicrobial resistance.
  • The growing global focus on preventing HAIs post-surgery, coupled with the escalating challenge of antimicrobial resistance, has spurred heightened interest in Ondine’s photodisinfection technology.
  • The antibiotic mupirocin has been used for nasal decolonization for the prevention of HAIs since the 1980s.

Large Clinical Trial by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA Healthcare and UCI Health Identifies Best Strategy to Prevent Life-Threatening Health Care-Associated ICU Infections

Retrieved on: 
Tuesday, October 10, 2023
Research, Hospitals, Clinical Trials, Health Insurance, Other Health, Managed Care, Health, Pharmaceutical, Science, Chlorhexidine, JAMA, Multimedia, Hospital, Harvard Medical School, Bloodstream infections, Health care, Division, Mupirocin, Suggestion, Bacteria, University of California, Irvine Medical Center, Master of Science, Risk, Intensive care unit, CDC, Antimalarial medication, University, Infection, American Medical Association, CHG, MRSA, Journal, Povidone-iodine, University of California, Irvine School of Medicine, Staphylococcus aureus, REDUCE, Nose, ICU, Additive effect, HCA Healthcare, Korea Disease Control and Prevention Agency, Skin, ABATE, Patient, Harvard Pilgrim Health Care, Pharmaceutical industry, Nursing, MD, Medicine

This strategy is called “decolonization” because it reduces the amount of bacteria on the body in order to reduce infection risk.

Key Points: 
  • This strategy is called “decolonization” because it reduces the amount of bacteria on the body in order to reduce infection risk.
  • The Mupirocin-Iodophor Swap Out Trial directly compared nasal mupirocin to nasal iodophor in the context of chlorhexidine bathing.
  • “This study further supports CDC guidance on using a strategy that combines nasal decolonization plus CHG bathing in ICU patients.
  • The results resolved the question about whether nasal treatment is necessary in addition to chlorhexidine bathing to prevent these ICU infections.

A Simple Antibacterial Treatment Solves a Severe Skin Problem Caused by Radiation Therapy

Retrieved on: 
Thursday, May 4, 2023
Albert Einstein College of Medicine, Infection, Skin infection, Radiation, MECC, Neoplasm, Dermatitis, Sore, Cancer, Quality of life, MacLellan, Staphylococcus aureus, Nose, JAMA Oncology, Dermatology, Mupirocin, Montefiore Medical Center, Standard of care, Swelling, Risk, Breast, B.A, Bacteria, Severity, SA, ARD, News, Skin, Breast cancer, Medical imaging, Pharmaceutical industry, Poultry farming, Patient, Aquaphor

BRONX, N.Y., May 4, 2023 /PRNewswire/ -- Acute radiation dermatitis (ARD)—characterized by red, sore, itchy or peeling skin—affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can cause significant swelling and painful skin ulcers that can severely impair quality of life, yet little is known about why this condition occurs and no standardized treatments for preventing severe ARD have been widely adapted.

Key Points: 
  • Researchers at Montefiore Einstein Cancer Center (MECC) have found that many cases of ARD involve a common skin bacterium and that a simple, low-cost treatment can prevent severe cases, potentially setting a new standard of care for people undergoing radiation therapy.
  • Each year, 10 million people are treated with radiation therapy to reduce the size of their tumors.
  • Radiation weakens the skin's structure at the treatment site and can result in infection by allowing SA to break through the skin's outer layer.
  • In one of the JAMA Oncology studies, the MECC researchers enrolled 76 patients undergoing radiation therapy for cancer.

Outlook on the HIV Vaccines Global Market to 2027 - Leading Healthcare Providers Venturing into HIV Space Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, August 29, 2022
AIDS, Health, Market development, Mupirocin, Observation, Porter's five forces analysis, Antibody, USD, Global, Ansoff Matrix, Investment, HIV, Emotion, Geography, SWOT, CAGR, Vaccine, Risk, COVID-19, Growth, Industry, Retail, Pharmaceutical industry, Dicloxacillin

Market dynamics are forces that impact the prices and behaviors of the Global HIV Vaccines Market stakeholders.

Key Points: 
  • Market dynamics are forces that impact the prices and behaviors of the Global HIV Vaccines Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global HIV Vaccines Market.
  • The analyst analyses the Global HIV Vaccines Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global HIV Vaccines Market.

VigiLanz Announces Winners of 2022 Vigi Awards

Retrieved on: 
Monday, August 15, 2022
Jackson Health System, Monkeypox, Documentation, Health care, Patient safety, Risk, Table, CMOS, CIOS, Houston Methodist The Woodlands Hospital, Houston Methodist Hospital, Infection, EHR, Hospital, Cardiology, Pharmacy, Software as a service, Compliance, Mupirocin, Patient, Cincinnati Children's Hospital Medical Center, COVID-19, HAI, Decision-making, Safety, Doctor of Philosophy, MRSA, Vancomycin, Culture, Workflow, Allergy, Rising Star, MD, Create, Pharmacist, Pharmaceutical industry, Medicine, Citrus, Healthcare, Medical device, Medical imaging

MINNEAPOLIS, Aug. 15, 2022 /PRNewswire/ -- VigiLanz, a clinical surveillance company, today announced the winners of the annual Vigi Awards, which honor innovative hospitals throughout the United States.

Key Points: 
  • MINNEAPOLIS, Aug. 15, 2022 /PRNewswire/ -- VigiLanz , a clinical surveillance company, today announced the winners of the annual Vigi Awards, which honor innovative hospitals throughout the United States.
  • The award winners are selected by VigiLanz based on nominations of individuals and teams submitted by VigiLanz customers.
  • "We are incredibly proud of this year's Vigi Award winners, and it is our honor to recognize them for their amazing accomplishments and achievements," said David Goldsteen, MD, VigiLanz CEO.
  • For more information on the Vigi Awards and award winners, please visit the VigiLanz website .

Global Burn Ointment Market (2022 to 2027) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 19, 2022
Health, Pharmaceutical, Population, R, Ageing, National Center for Biotechnology Information, Polymyxin B, Incidence, National Center for Health Statistics, Burn, Nystatin, Royal Australian College of General Practitioners, Royal college, Silver, Iodine, Neomycin/polymyxin B/bacitracin, General officer, Awareness, Megasphaera, Hospital, Burns, Growth, NCBI, Health insurance, Renewable energy, Bacitracin, Mupirocin, Nitrofurazone

The topical antibiotics segment is expected to hold a significant market share during the forecast period.

Key Points: 
  • The topical antibiotics segment is expected to hold a significant market share during the forecast period.
  • The major factors propelling the growth of this segment include the high acceptance of burn ointment products in home-care settings and the rising incidence of burns across the globe.
  • Mafenide acetate, Bacitracin, Mupirocin, Neosporin, Polymyxin B, Nitrofurazone, and Nystatin are the widely accepted topical antibiotics burn ointments.
  • As per the Royal Australian College of General Practitioners 2017 report, stated burn injuries are common and costly.